Cash & Short-Term Investments

$7.99B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$7.99Bperiod endingJun 30, 2026

REGN Quarterly Cash & Short-Term Investments ($21.80M → $7.99B)

Quarterly Cash & Short-Term Investments

High-resolution chart · PNG

REGN cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Cash & Short-Term Investments — Quarterly (USD)
Period ending	Cash & Short-Term Investments (USD)
Jun 30, 2001	244,807,000
Mar 31, 2001	274,003,000
Dec 31, 2000	117,612,000
Sep 30, 2000	117,028,000
Jun 30, 2000	117,861,000
Mar 31, 2000	56,414,000
Dec 31, 1999	66,200,000
Sep 30, 1999	64,000,000
Jun 30, 1999	20,600,000
Mar 31, 1999	21,800,000
Dec 31, 1998	19,800,000
Sep 30, 1998	22,600,000
Jun 30, 1998	22,500,000
Mar 31, 1998	19,300,000
Dec 31, 1997	28,900,000
Sep 30, 1997	40,300,000
Jun 30, 1997	51,400,000
Mar 31, 1997	27,900,000
Dec 31, 1996	34,500,000
Sep 30, 1996	37,500,000
Jun 30, 1996	48,900,000
Mar 31, 1996	11,900,000
Dec 31, 1995	32,700,000
Sep 30, 1995	5,900,000
Jun 30, 1995	16,800,000
Mar 31, 1995	12,700,000
Dec 31, 1994	23,600,000
Sep 30, 1994	15,300,000
Jun 30, 1994	18,000,000
Mar 31, 1994	8,000,000
Dec 31, 1993	12,500,000
Sep 30, 1993	39,700,000
Jun 30, 1993	7,900,000
Mar 31, 1993	10,100,000
Dec 31, 1992	16,400,000
Sep 30, 1992	19,200,000
Jun 30, 1992	22,000,000
Mar 31, 1992	24,900,000
Dec 31, 1991	26,200,000
Sep 30, 1991	35,000,000
Jun 30, 1991	39,200,000
Dec 31, 1990	21,800,000